Haakon Hoftun • 1988 • Oslo • 3 roles • 4 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
L LAB PHARMA AS	Managing Director/CEO	50,674,735	5,433,832	100 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
L LAB PHARMA AS	Chairman	50,674,735	5,433,832	100 % indirectly
T TER REK AS	Chairman	546,750	18,879,919	100 % directly

Last update: Apr 13, 2023

Related industries

No related industries

Direct relationships

1

CH
Cybele Hoftun1964
LAB PHARMA AS, TER REK AS

Shares owned by Haakon Ringerike Hoftun

Name	Share class	Total operating income	Total equity	Share
T TER REK AS	Ordinære aksjer	546,750	18,879,919	100 % directly
L LAB PHARMA AS		50,674,735	5,433,832	100 % indirectly
C COMROD HOLDING AS	Ordinære aksjer	0	3,090,163	< 0.01 % directly
C COMROD COMMUNICATION AS	Ordinære aksjer	39,230,177	40,927,018	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026